168 related articles for article (PubMed ID: 31781846)
1. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
Sun J; Yu W; Zhang X
Ann Hematol; 2020 Jan; 99(1):185-188. PubMed ID: 31781846
[No Abstract] [Full Text] [Related]
2. MEF2D-BCL9 B-Lymphoblastic Leukemia Blast Morphology Does Not Always Mimic Mature B-Cell Leukemia.
Baek HJ; Choi YJ; Kim BR; Lee JH; Shin MG; Kook H
J Pediatr Hematol Oncol; 2021 Apr; 43(3):112-113. PubMed ID: 33235148
[TBL] [Abstract][Full Text] [Related]
3. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.
Raynaud S; Mauvieux L; Cayuela JM; Bastard C; Bilhou-Nabera C; Debuire B; Bories D; Boucheix C; Charrin C; Fière D; Gabert J
Leukemia; 1996 Sep; 10(9):1529-30. PubMed ID: 8751475
[No Abstract] [Full Text] [Related]
4. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
5. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Gu Z; Churchman M; Roberts K; Li Y; Liu Y; Harvey RC; McCastlain K; Reshmi SC; Payne-Turner D; Iacobucci I; Shao Y; Chen IM; Valentine M; Pei D; Mungall KL; Mungall AJ; Ma Y; Moore R; Marra M; Stonerock E; Gastier-Foster JM; Devidas M; Dai Y; Wood B; Borowitz M; Larsen EE; Maloney K; Mattano LA; Angiolillo A; Salzer WL; Burke MJ; Gianni F; Spinelli O; Radich JP; Minden MD; Moorman AV; Patel B; Fielding AK; Rowe JM; Luger SM; Bhatia R; Aldoss I; Forman SJ; Kohlschmidt J; Mrózek K; Marcucci G; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Paietta E; Willman CL; Loh ML; Hunger SP; Mullighan CG
Nat Commun; 2016 Nov; 7():13331. PubMed ID: 27824051
[TBL] [Abstract][Full Text] [Related]
6. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia.
Sonoki T; Iwanaga E; Mitsuya H; Asou N
Leukemia; 2005 Nov; 19(11):2009-10. PubMed ID: 16151463
[No Abstract] [Full Text] [Related]
7. Characterization of a novel
Van Outersterp I; Hormann FM; Hoogkamer AQ; Boeree A; Van den Broek SA; Den Boer ML; Boer JM
Haematologica; 2023 Oct; 108(10):2859-2864. PubMed ID: 37051743
[No Abstract] [Full Text] [Related]
8. WT1 protein expression in childhood acute leukemia.
Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
[TBL] [Abstract][Full Text] [Related]
9. The pathogenic role of MEF2D-SS18 fusion gene in B-cell acute lymphoblastic leukemia.
Zhang M; Mao D; Zhang W
Biochem Biophys Res Commun; 2018 Feb; 496(4):1331-1336. PubMed ID: 29408457
[TBL] [Abstract][Full Text] [Related]
10. TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group.
Seeger K; Buchwald D; Taube T; Peter A; von Stackelberg A; Schmitt G; Köchling J; Henze G
Leukemia; 1999 Sep; 13(9):1469-70. PubMed ID: 10483004
[No Abstract] [Full Text] [Related]
11. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukaemia of precursor B-cell origin.
Potter MN; Steward CG; Maitland N; Oakhill A
Leukemia; 1992 Apr; 6(4):354-5. PubMed ID: 1588799
[No Abstract] [Full Text] [Related]
12. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
Gao J; Yuan LX; Sun L; Li XX; Liao QK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
[TBL] [Abstract][Full Text] [Related]
13. IDH1
Zhang X; Suo S; Wang J; Jin J; Yu W
Br J Haematol; 2021 Jan; 192(2):e44-e47. PubMed ID: 33222166
[No Abstract] [Full Text] [Related]
14. Significantly lower relapse rate for TEL/AML1-positive ALL.
Zuna J; Hrusák O; Kalinová M; Muzíková K; Starý J; Trka J
Leukemia; 1999 Oct; 13(10):1633. PubMed ID: 10516768
[No Abstract] [Full Text] [Related]
15. Outcome and molecular measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia patients with MEF2D fusions.
Sun K; Chen WM; Wang X; Zhao XS; Li LD; Hao Y; Wang J; Xu N; Jiang Q; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Qin YZ
Hematol Oncol; 2023 Aug; 41(3):594-597. PubMed ID: 36516881
[No Abstract] [Full Text] [Related]
16. Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells.
Tange N; Hayakawa F; Yasuda T; Odaira K; Yamamoto H; Hirano D; Sakai T; Terakura S; Tsuzuki S; Kiyoi H
Biomed Pharmacother; 2020 Aug; 128():110330. PubMed ID: 32504922
[TBL] [Abstract][Full Text] [Related]
17. [Translocation (4;11) associated with mature B-line acute lymphoblastic leukemia in an adult patient].
Granada I; Ribera JM; Juncà J; Millá F; Feliu E
Sangre (Barc); 1992 Oct; 37(5):413-4. PubMed ID: 1293787
[No Abstract] [Full Text] [Related]
18. A 33-year-old man with an unclassifiable acute lymphoblastic leukemia.
Kramer MH; Kluin-Nelemans JC; Beverstock GC; Kluin PM; Bieger R
Ann Hematol; 1991 May; 62(5):196-200. PubMed ID: 2049470
[No Abstract] [Full Text] [Related]
19. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
[TBL] [Abstract][Full Text] [Related]
20. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]